Akagera Medicines, a Rwandan biotech company has announced promising results after completing early stages of preclinical trials of an antibiotic drug for the treatment of pulmonary tuberculosis (TB).

TB cases rise globally. New vaccine trials offer hope. Learn about TB's impact, risks, and a Dr. Alemnew Dagnew's fight for a ...

Mandimycin, which targets a different essential fungi cell resource than other antifungal drugs, should harm other cell types as collateral — but doesn’t.

The University of Oxford has commenced a new clinical trial called TB-45, which will test tuberculosis (TB) vaccine safety ...

The WHO reports that tuberculosis cases in children are rising globally. Experts say a rise in TB cases in Europe could mean ...

A woman in Ireland was mistakenly given the wrong vaccine, resulting in a severe abscess and whole-body infection that ...

Know about top innovations that will be part of the national TB elimination programme, help in screening and treatment.

It’s been three months since a global tuberculosis (TB) drug shortage was first reported. Motherwell Community Health Centre in Gqeberha, Eastern Cape is only left with five boxes of Rifinah, a ...

Dr. Pavan YadavLead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital 24th marks World ...

The umbrella programme Data Driven Research to Eradicate TB (Dare2eraD TB) was launched in March 2022 and included setting up ...

In Thailand, around 113,000 new TB cases and more than 13,000 deaths were reported in 2024, marking TB as a serious public ...

In an exclusive interview with Rashmi Mabiyan Kaur, Dr. Sandeep Nayar, Principal Director and HOD, Chest and Respiratory ...